Review of Gallium-68 PSMA PET/CT Imaging in the Management of Prostate Cancer

Over 90% of prostate cancers over-express prostate specific membrane antigen (PSMA) and these tumor cells may be accurately targeted for diagnosis by (68)Ga-PSMA-positron emission tomography/computed tomography ((68)Ga-PSMA-PET/CT) imaging. This novel molecular imaging modality appears clinically to...

Descripción completa

Detalles Bibliográficos
Autores principales: Lenzo, Nat P., Meyrick, Danielle, Turner, J. Harvey
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5871999/
https://www.ncbi.nlm.nih.gov/pubmed/29439481
http://dx.doi.org/10.3390/diagnostics8010016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5871999/
https://www.ncbi.nlm.nih.gov/pubmed/29439481
http://dx.doi.org/10.3390/diagnostics8010016

Ejemplares similares